[HTML][HTML] Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

…, DA Norris, R Crean, DL Graham, E Huang, E Ratti… - Nature medicine, 2023 - nature.com
Tau plays a key role in Alzheimer’s disease (AD) pathophysiology, and accumulating
evidence suggests that lowering tau may reduce this pathology. We sought to inhibit MAPT …

Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates

…, D Montanari, T Rossi, E Ratti - Expert Opinion on Drug …, 2010 - Taylor & Francis
… values are calculated, it becomes apparent that Drugs A and B have a significantly higher
efficiency with 15- to 20-fold higher biophase concentrations with respect to Drugs C, D and E. …

Microalbuminuria, cardiovascular, and renal risk in primary hypertension

…, M Ravera, F Viazzi, S Vettoretti, E Ratto… - Journal of the …, 2002 - journals.lww.com
ABSTRACT. Microalbuminuria is defined as abnormal urinary excretion of albumin between
30 and 300 mg/d. It can be measured accurately by several widely available and sensitive …

[HTML][HTML] Presynaptic AMPA receptors in health and disease

L Zanetti, M Regoni, E Ratti, F Valtorta, J Sassone - Cells, 2021 - mdpi.com
AMPA receptors (AMPARs) are ionotropic glutamate receptors that play a major role in
excitatory neurotransmission. AMPARs are located at both presynaptic and postsynaptic plasma …

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression

…, AA Freeman, MM Sanchez, NH Kalin, E Ratti… - Biological …, 2007 - Elsevier
BACKGROUND: Interferon (IFN)-alpha is an innate immune cytokine that causes high rates
of depression in humans and therefore has been used to study the impact of cytokines on …

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients

…, DS Hartman, T Ishikawa, E Ratti… - Proceedings of the …, 2022 - National Acad Sciences
Narcolepsy type 1 (NT1) is a sleep disorder caused by a loss of orexinergic neurons. Narcolepsy
type 2 (NT2) is heterogeneous; affected individuals typically have normal orexin levels. …

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a …

…, LS Schneider, K Yaffe, AM Saunders, E Ratti… - The Lancet …, 2021 - thelancet.com
Background The identification of people at risk of cognitive impairment is essential for improving
recruitment in secondary prevention trials of Alzheimer's disease. We aimed to test and …

[HTML][HTML] Comparison of medical and consumer wireless EEG systems for use in clinical trials

E Ratti, S Waninger, C Berka, G Ruffini… - Frontiers in human …, 2017 - frontiersin.org
Objectives: To compare quantitative EEG signal and test-retest reliability of medical grade and
consumer EEG systems. Methods: Resting state EEG was acquired by two medical grade (…

The outburst decay of the low magnetic field magnetar SGR 0418+ 5729

…, D Götz, RP Mignani, E Ratti… - The Astrophysical …, 2013 - iopscience.iop.org
e The BB radius in km is the square root of this BB normalization, times the distance in
units of 10 kpc. * See Section 3.1 for details on the modeling of these observations. … The …

Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells

…, A Zamburlini, FTM van Amsterdam, E Ratti… - Archives of biochemistry …, 1992 - Elsevier
One of the major biological targets of free radical oxidations, prone, for anatomical reasons,
to oxidative challenges, is the cardiovascular system. In the present paper the effect of …